Abstract
Nuclear magnetic resonance (NMR) and Mass Spectroscopy (MS) are the two most common spectroscopic analytical techniques employed in metabolomics. The large spectral datasets generated by NMR and MS are often analyzed using data reduction techniques like Principal Component Analysis (PCA). Although rapid, these methods are susceptible to solvent and matrix effects, high rates of false positives, lack of reproducibility and limited data transferability from one platform to the next. Given these limitations, a growing trend in both NMR and MS-based metabolomics is towards targeted profiling or “quantitative” metabolomics, wherein compounds are identified and quantified via spectral fitting prior to any statistical analysis. Despite the obvious advantages of this method, targeted profiling is hindered by the time required to perform manual or computer-assisted spectral fitting. In an effort to increase data analysis throughput for NMR-based metabolomics, we have developed an automatic method for identifying and quantifying metabolites in one-dimensional (1D) proton NMR spectra. This new algorithm is capable of using carefully constructed reference spectra and optimizing thousands of variables to reconstruct experimental NMR spectra of biofluids using rules and concepts derived from physical chemistry and NMR theory. The automated profiling program has been tested against spectra of synthetic mixtures as well as biological spectra of urine, serum and cerebral spinal fluid (CSF). Our results indicate that the algorithm can correctly identify compounds with high fidelity in each biofluid sample (except for urine). Furthermore, the metabolite concentrations exhibit a very high correlation with both simulated and manually-detected values.
Similar content being viewed by others
References
Aich P, Potter AA, Griebel PJ (2009) Modern approaches to understanding stress and disease susceptibility: a review with special emphasis on respiratory disease. Int J Gen Med 2:19–32
Altman DG, Bland JM (1994) Diagnostic tests 1: sensitivity and specificity. BMJ 308:1552
Beckonert O, Coen M, Keun HC, Wang Y, Ebbels TM, Holmes E, Lindon JC, Nicholson JK (2010) High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues. Nat Protoc 5:1019–1032
Bertram HC, Eggers N, Eller N (2009) Potential of human saliva for nuclear magnetic resonance-based metabolomics and for health-related biomarker identification. Anal Chem 81:9188–9193
Bezabeh T, Somorjai RL, Smith ICP (2009) MR metabolomics of fecal extracts: applications in the study of bowel diseases. Magn Reson Chem 47:S54–S61
Cevallos-Cevallos JM, Reyes-De-Corcuera JI, Etxeberria E, Danyluk MD, Rodrick GE (2009) Metabolomic analysis in food science: a review. Trends Food Sci Tech 20:557–566
Chang D, Banack CD, Shah SL (2007a) Robust baseline correction algorithm for signal dense NMR spectra. J Magn Reson 187:288–292
Chang D, Weljie A, Newton J (2007b) Leveraging latent information in NMR spectra for robust predictive models. Pac Symp Biocomput 115–126
Chen C, Gonzalez FJ, Idle JR (2007a) LC-MS-based metabolomics in drug metabolism. Drug Metab Rev 39:581–597
Chen DJ, Lee CY, Park CH, Mendes P (2007b) Parallelizing simulated annealing algorithms based on high-performance computer. J Global Optim 39:261–289
Chenomx Nmr Suite (2010) Chenomx Inc., Edmonton, AB, Canada. http://www.chenomx.com
Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF, Westler WM, Eghbalnia HR, Sussman MR, Markley JL (2008) Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol 26:162–164
Fonville JM, Maher AD, Coen M, Holmes E, Lindon JC, Nicholson JK (2010) Evaluation of full-resolution J-resolved 1H NMR projections of biofluids for metabonomics information retrieval and biomarker identification. Anal Chem 82:1811–1821
Frassineti C, Ghelli S, Gans P, Sabatini A, Moruzzi MS, Vacca A (1995) Nuclear magnetic resonance as a tool for determining protonation constants of natural polyprotic bases in solution. Anal Biochem 231:374–382
Griffin JL, Kauppinen RA (2007) Tumour metabolomics in animal models of human cancer. J Proteome Res 6:498–505
Hall RD, Brouwer ID, Fitzgerald MA (2008) Plant metabolomics and its potential application for human nutrition. Physiol Plant 132:162–175
Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48:653–683
Keun HC (2006) Metabonomic modeling of drug toxicity. Pharmacol Ther 109:92–106
Kim YS, Maruvada P, Milner JA (2008) Metabolomics in biomarker discovery: future uses for cancer prevention. Futur Oncol 4:93–102
Kim K, Aronov P, Zakharkin SO, Anderson D, Perroud B, Thompson IM, Weiss RH (2009) Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics 8:558–570
Kimura T, Noguchi Y, Shikata N, Takahashi M (2009) Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks. Curr Opin Clin Nutr Metab Care 12:49–53
Kristal BS, Shurubor Y, Marur V (2007) Projection-based informatics approaches to serum/plasma metabolomics data: applications to biomarkers for caloric intake in rats. Faseb J 21:A310–A310
Li H, Jiang Y, He FC (2008) Recent development of metabonomics and its applications in clinical research. Yi Chuan 30:389–399
Lindon JC, Nicholson JK (2008) Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem 1:45–69
Lindon JC, Nicholson JK, Holmes E (2007) The handbook of metabonomics and metabolomics, 1st edn. Elsevier, Amsterdam
Markley JL, Anderson ME, Cui Q, Eghbalnia HR, Lewis IA, Hegeman AD, Li J, Schulte CF, Sussman MR, Westler WM, Ulrich EL, Zolnai Z (2007) New bioinformatics resources for metabolomics. Pac Symp Biocomput 157–168
Milgram E, Nordstrom A (2009) Asms metabolomics workshop survey. http://fiehnlab.ucdavis.edu/staff/kind/Metabolomics-Survey-2009/
Moore JG, Sillerud OL (1994) The pH dependence of chemical shift and spin-spin coupling for citrate. J Magn Res B 103:87–88
Morris GA, Barjat H, Home TJ (1997) Reference deconvolution methods. Prog Nucl Mag Res Sp 31:197–257
Oakman C, Tenori L, Biganzoli L, Santarpia L, Cappadona S, Luchinat C, Di Leo A (2010) Uncovering the metabolomic fingerprint of breast cancer. Int J Biochem Cell Biol
Odunsi K (2007) Cancer diagnostics using 1H-NMR-based metabonomics. Ernst Schering Found Symp Proc 4:205–226
Poullet JB, Sima DM, Simonetti AW, De Neuter B, Vanhamme L, Lemmerling P, Van Huffel S (2007) An automated quantitation of short echo time MRS spectra in an open source software environment: AQSES. NMR Biomed 20:493–504
Poullet JB, Sima DM, Van Huffel S (2008) MRS signal quantitation: a review of time- and frequency-domain methods. J Magn Reson 195:134–144
Quinones MP, Kaddurah-Daouk R (2009) Metabolomics tools for identifying biomarkers for neuropsychiatric diseases. Neurobiol Dis 35:165–176
Scalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, van Ommen B, Pujos-Guillot E, Verheij E, Wishart D, Wopereis S (2009) Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 5:435–458
Schiffmann R, Waldek S, Benigni A, Auray-Blais C (2010) Biomarkers of Fabry disease nephropathy. Clin J Am Soc Nephrol 5:360–364
Serkova NJ, Niemann CU (2006) Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics. Expert Rev Mol Diagn 6:717–731
Sima DM, Van Huffel S (2006) Regularized semiparametric model identification with application to nuclear magnetic resonance signal quantification with unknown macromolecular base-line. J Roy Stat Soc B 68:383–409
Sinclair AJ, Viant MR, Ball AK, Burdon MA, Walker EA, Stewart PM, Rauz S, Young SP (2010) NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases—a diagnostic tool? NMR Biomed 23:123–132
Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15:431–440
Staab JM, O’Connell TM, Gomez SM (2010) Enhancing metabolomic data analysis with Progressive Consensus Alignment of NMR Spectra (PCANS). BMC Bioinform 11:123
Stein SE, Scott DR (1994) Optimization and testing of mass-spectral library search algorithms for compoud identification. J Am Soc Mass Spectr 5:859–866
Tainsky MA (2009) Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim Biophys Acta 1796:176–193
Tiziani S, Lopes V, Gunther UL (2009) Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia 11:269–276
Van Der Graaf M, Heerschap A (1996) Effect of cation binding on the proton chemical shifts and the spin-spin coupling constant of citrate. J Magn Res B 112:58–62
Vangala S, Tonelli A (2007) Biomarkers, metabonomics, and drug development: can inborn errors of metabolism help in understanding drug toxicity? AAPS J 9:E284–E297
Veselkov KA, Lindon JC, Ebbels TMD, Crockford D, Volynkin VV, Holmes E, Davies DB, Nicholson JK (2009) Recursive segment-wise peak alignment of biological 1H NMR spectra for improved metabolic biomarker recovery. Anal Chem 81:56–66
Waterman CL, Kian-Kai C, Griffin JL (2010) Metabolomic strategies to study lipotoxicity in cardiovascular disease. Biochim Biophys Acta 1801:230–234
Weiss RH, Kim K, Tolstikov V (2008) Use of urinary metabolomics to identify biomarkers for kidney cancer. Cancer Biomark 4:167–167
Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM (2006) Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78:4430–4442
Wishart DS (2008a) Applications of metabolomics in drug discovery and development. Drugs R&d 9:307–322
Wishart DS (2008b) Metabolomics: applications to food science and nutrition research. Trends Food Sci Tech 19:482–493
Wishart DS (2008c) Quantitative metabolomics using NMR. Trac-trend Anal Chem 27:228–237
Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R, Li L (2008) The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci 871:164–173
Wolfender JL, Glauser G, Boccard J, Rudaz S (2009) MS-based plant metabolomic approaches for biomarker discovery. Nat Prod Commun 4:1417–1430
Woo HM, Kim KM, Choi MH, Jung BH, Lee J, Kong G, Nam SJ, Kim S, Bai SW, Chung BC (2009) Mass spectrometry based metabolomic approaches in urinary biomarker study of women’s cancers. Clin Chim Acta 400:63–69
Xi Y, Rocke DM (2008) Baseline correction for NMR spectroscopic metabolomics data analysis. BMC Bioinform 9:324
Xia JG, Bjorndahl TC, Tang P, Wishart DS (2008) MetaboMiner—semi-automated identification of metabolites from 2D NMR spectra of complex biofluids. Bmc Bioinform 9:ARTN 507
Young SP, Wallace GR (2009) Metabolomic analysis of human disease and its application to the eye. J Ocul Biol Dis Infor 2:235–242
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mercier, P., Lewis, M.J., Chang, D. et al. Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra. J Biomol NMR 49, 307–323 (2011). https://doi.org/10.1007/s10858-011-9480-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10858-011-9480-x